Varicose Veins Presentation
Patient with visible varicose veins
All Pathways
Vascular SurgeryManagement
Varicose Veins Management (NICE 2023)
Varicose Veins Management (NICE 2023): Varicose Veins Presentation → Clinical Assessment → Symptom Severity → Cosmetic Concern Only.
Pathway Overview
16 steps
Algorithm Steps
16 total
01Start 02Action Clinical Assessment
History and examination
- Symptoms: aching, heaviness, itching, cramps
- Impact on quality of life
- Previous DVT or treatment
- Distribution: GSV, SSV, or both
- Skin changes (CEAP C4-C6)
03Decision Symptom Severity
Symptomatic vs cosmetic concern
04Action Cosmetic Concern Only
No significant symptoms
- Not typically covered by NHS/insurance
- Reassurance and lifestyle advice
- Compression if desired
- Private treatment options available
- Microsclerotherapy for telangiectasias
05Action Symptomatic Varicose Veins
Intervention indicated
- Leg symptoms attributable to VV
- Offer referral to vascular service
- Duplex scan mandatory before treatment
- Discuss treatment options
- Do not offer compression as definitive treatment
06Action Duplex Ultrasound
Essential before any intervention
- Map superficial reflux (GSV, SSV, AASV)
- Assess deep system patency
- Identify incompetent perforators
- Measure vein diameters
- Document reflux duration (>0.5s significant)
07Decision Treatment Selection
Based on anatomy and patient factors
08Action Endothermal Ablation
First-line treatment (NICE recommendation)
- Radiofrequency ablation (RFA) or
- Endovenous laser ablation (EVLA)
- Tumescent local anesthesia
- Day case procedure
- Equivalent efficacy, operator preference
09Action Concomitant Phlebectomies
Treat tributary varicosities
- Ambulatory phlebectomy
- Stab avulsions through 2-3mm incisions
- Same session as truncal ablation
- Or staged if extensive
- Local anesthesia sufficient
10Action Post-Procedure Care
Recovery and surveillance
- Compression stockings 1-2 weeks
- Walking encouraged immediately
- Return to work 1-3 days (endovenous)
- Duplex at 6 weeks to confirm closure
- Treat residual veins if needed
11Outcome Treatment Success
Symptoms improved; annual clinical review if concerns
12Outcome Recurrence
Re-scan; treat new reflux source; 15-20% at 5 years
13Action Non-Thermal Ablation
Alternative if thermal unsuitable
- Cyanoacrylate glue (VenaSeal)
- Mechanochemical ablation (MOCA/ClariVein)
- No tumescent anesthesia needed
- Suitable for tortuous veins
- Good short-term outcomes
- Path rejoins step 09Shared downstream outcome
14Action Foam Sclerotherapy
If ablation unsuitable
- Ultrasound-guided foam sclerotherapy
- Polidocanol or sodium tetradecyl sulfate
- Multiple sessions often needed
- Higher recurrence than ablation
- Suitable for recurrent/residual veins
- Path rejoins step 10Shared downstream outcome
15Action Surgical Treatment
If endovenous unsuitable
- High ligation + stripping (HL+S)
- General or regional anesthesia
- Concomitant phlebectomies
- Higher recurrence at SFJ/SPJ
- Reserved for specific anatomies
- Path rejoins step 10Shared downstream outcome
16Action Complicated Varicose Veins
Bleeding, thrombophlebitis, or ulcer
- URGENT referral (2 weeks for bleeding/ulcer)
- C5-C6: healed or active ulcer
- Superficial thrombophlebitis
- Bleeding varicose vein history
- Prioritize for treatment
- Path rejoins step 06Shared downstream outcome
Guideline Source
NICE 2023 Varicose Veins: Diagnosis and Management NG158
Clinical Safety Information
Clinical Decision Support — Not a Substitute for Clinical Judgment
Individual patient factors may require deviation from these recommendations.
Known Limitations
- Does not cover deep venous disease (see CVI algorithm)
- Cosmetic treatment not covered by most insurers
- Recurrence 15-20% at 5 years regardless of method
- Patient preference important in treatment selection
- Pregnancy: defer treatment until 6 months postpartum
Contraindicated Populations
Active DVT - treat DVT firstPregnancy - defer treatment
Applicable Regions
USEUUKGlobal
EU: ESVS guidelines similar
UK: NICE NG158 is standard; commissioning criteria apply
US: SVS guidelines; insurance coverage varies
Version 1Next review: 2027-01-01
Next steps
Finish the workflow by opening the most relevant calculator, then convert the session into a live account when you are ready.
Related Resources
Frequently Asked Questions
What is the Varicose Veins Management (NICE 2023)?
The Varicose Veins Management (NICE 2023) is a management clinical algorithm for Vascular Surgery. It provides a structured decision tree to guide clinical decision-making, based on NICE 2023 Varicose Veins: Diagnosis and Management NG158.
What guideline is the Varicose Veins Management (NICE 2023) based on?
This algorithm is based on NICE 2023 Varicose Veins: Diagnosis and Management NG158 (DOI: 10.1016/j.jvs.2011.01.079).
What are the limitations of the Varicose Veins Management (NICE 2023)?
Known limitations include: Does not cover deep venous disease (see CVI algorithm); Cosmetic treatment not covered by most insurers; Recurrence 15-20% at 5 years regardless of method; Patient preference important in treatment selection; Pregnancy: defer treatment until 6 months postpartum. Individual patient factors may require deviation from these recommendations.
Get AI-Powered Analysis Alongside This Algorithm
In AttendMe.ai, the Varicose Veins Management (NICE 2023) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.
Try AttendMe Free